Navigation Links
Ethiopian development raises birth rate

Development projects designed to improve maternal and child welfare in Africa may incur unexpected costs associated with increases in family size if they do not include a component of family planning, according to new research from the University of Bristol into rural communities in Ethiopia.

The research, published today in Public Library of Science: Medicine, is the first study to demonstrate a link between a single technological development intervention (in this case, a tapped water supply) and an increase in both birth rate and childhood malnutrition.

Dr Mhairi Gibson of Bristol University's Department of Archaeology and Anthropology and Dr Ruth Mace of University College, London examined nearly 2,000 households in rural Ethiopia over a four year period during which a tapped water supply was introduced but family planning provisions were absent. They looked at the nutritional status of women and children (in terms of weight and height) and birth rates in villages where tapped water had been introduced and others where it had not.

While previously, women had to walk up to 30 km to fetch their families' water, the new water supply reduced the time spent carrying water each day from around three hours to about 15 minutes. The availability of tapped water improved the survival of young children and the birth rate increased. However, the nutritional status of young children declined.

Overall, neither women's health nor nutritional status appeared to be improved by the reduced workload, lending support to the idea that the energy women save due to new development technology is being diverted towards reproduction, resulting in greater fertility and reduced mortality. However, since food and other resources are already scarce, this comes at the cost of an increase in childhood malnutrition.

Dr Gibson said: "This study is, to our knowledge, the first to demonstrate a link between a technological development intervention and
'"/>

Source:University of Bristol


Page: 1 2

Related biology news :

1. A much-needed shot in the arm for HIV vaccine development
2. Clam embryo study shows pollutant mixture adversely affects nerve cell development
3. Zebrafish may hold key to understanding human nerve cell development
4. Scientists identify new model Of NK cell development
5. Influenza vaccine uses insect cells to speed development
6. Chemists identify key gene in development of type 1 diabetes
7. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
8. Liposome finding implies electrical effect on cell development
9. Multi-purpose protein regulates new protein synthesis and immune cell development
10. Gene keeps neural cells on correct developmental path
11. B cells are required for development of epithelial cancer associated with chronic inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ethiopian development raises birth rate

(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... government for a license to perform a second field trial ... a slightly different composition, meaning that it can be converted ... manner. One of the aims of the field trial is ... Another aim will be to expose the wood from the ...
... the Institute of Molecular and Cell Biology (IMCB) have identified ... constructing stable haploid strains of Candida albicans ... made by two teams of scientists led by Prof Wang ... University of Minnesota, will enable scientists to effectively target and ...
... VA Cartilage tympanoplasty can be performed successfully in ... according to a study in the February 2013 issue ... tympanoplasty is a frequently performed procedure with varying reported ... In general, tympanic membrane repair success in children is ...
Cached Biology News:VIB applies for second poplar field trial 2A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans 2
(Date:8/27/2015)... Poway, CA (PRWEB) , ... August 27, 2015 ... ... a unique opportunity for venture capital funds, investment firms and animal health companies ... the Forum have raised $160 million. Several have also received licensing agreements or ...
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage ... Exchange: PBT.U), and Biohaven Pharmaceutical Holding Company Limited ... a Phase I study of BHV-0223, a glutamate ... (IND) regarding BHV-0223 and recently obtained clearance from ... proceed with human testing. Portage holds 54% equity ...
(Date:8/27/2015)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results ... complete second quarter financial statements and MD&A have been filed on ... per shareThree-months ended , Six -months endedJune 30 , June 30 ... 2014 Revenue , 4,709 , 2,459 ... 1,656 , 56 , 3,188 , ...
(Date:8/27/2015)... ... 27, 2015 , ... Inc. Magazine released its annual list of the 5,000 ... in growth for the three years through 2014. Being named to the Inc. 5000 ... in the country. , “We are thrilled to make the Inc. 5000 list ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3
... 30 ITGI Medical,Ltd. (TASE: ITGI) a company ... tissue covered stents,announced that its second heterologous tissue ... AneuGraft(R) is a stent 100% covered with a ... coronary blood vessel wall and its,lumen. It is ...
... (Amex:,ULU) today announced that it has filed a ... Administration (FDA) for Altrazeal(TM) Silver., Preclinical studies ... healing rates in numerous porcine wound models have ... toxicology and,in vitro bacteria inhibition studies Altrazeal(TM) Silver ...
... named Robert P. Hammer, Ph.D., director of chemical development. , ... ... Peptide, LLC (NEP), has named Robert P. Hammer, Ph.D., director of ... University (LSU), where he was the William A. Pryor professor of ...
Cached Biology Technology:ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels 2ULURU Inc. Announces the Filing of a 510k Submission With the FDA for Altrazeal(TM) Silver 2ULURU Inc. Announces the Filing of a 510k Submission With the FDA for Altrazeal(TM) Silver 3New England Peptide Names Director of Chemical Development 2
Request Info...
albumin from bovine serum (BSA), fluorescein conjugate...
... Processing mini Tray (3 per pack), ... staining and blot processing.Automated staining of ... proteins and nucleic acid analysis.Prepares blots ... chromogenic detection.Programmable control of protocol, solution, ...
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
Biology Products: